Alligator Bioscience appoints Søren Bregenholt as new CEO

Alligator Bioscience appoints Søren Bregenholt as new CEO Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søren Bregenholt, Ph.D. as the company’s new Chief Executive Officer (CEO), to strengthen Alligator’s...

Zealand Pharma completes registration of capital increase

Zealand Pharma completes registration of capital increase Zealand Pharma A/S announces that it has today, as part of completion of a directed issue and private placement (the “Offering”), registered with the Danish Business Authority, the capital increase...

Alligator Bioscience’s rights issue oversubscribed

Alligator Bioscience’s rights issue oversubscribed Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has completed the share issue with pre-emption rights for the Company’s shareholders, which was resolved upon by the Board of Directors on December 15,...